Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson

TipRanks’ AI analyst rates Capital Group Dividend Value ETF ($CGDV), Invesco S&P 500 Momentum ETF ($SPMO), and JPMorgan Equity Premium Income ETF (...

3 ETFs with 12%+ Upside for Exposure to Tech, Industrials, and Healthcare, According to AI Analyst

Insiders have been trading these 5 stocks: (($NVDA)), (($TSM)), (($CRM)), (($CRWD)) and (($JNJ)). Here is a breakdown of their recent trades and th...

Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up

TipRanks’ AI analyst rates Dimensional U.S. Equity ETF ($DFUS), Alerian MLP ETF ($AMLP), and Vanguard Value ETF ($VTV) as Outperform (Buy) for expo...

3 ETFs with 10%+ Upside for Exposure to Finance, Health, and Energy, According to AI Analyst

TipRanks’ ETF AI Analyst has an Outperform rating on the Invesco NASDAQ 100 ETF ($QQQM), Vanguard High Dividend Yield Index ETF ($VYM), and iShares...

3 ETFs to Buy with 10%+ Total Returns, According to the AI Analyst

U.S. stocks finished Friday higher, ending a volatile week on a stronger note even as bond yields climbed and concerns over the country’s growing d...

The Week That Was, The Week Ahead: Macro and Markets, August 23

Johnson & Johnson ( ($JNJ) ) has been popular among investors this week. Here is a recap of the key news on this stock. Johnson & Johnson is back in


Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

Insiders have been trading these 5 stocks: (($JNJ)), (($ABBV)), (($CVX)), (($ET)) and (($HD)). Here is a breakdown of their recent trades and their...

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TipRanks’ ETF AI Analyst is bullish on Vanguard Value ETF ($VTV), Harbor Corporate Culture ETF ($HAPI), and Invesco ESG NASDAQ 100 ETF ($QQMG). It ...

These 3 ETFs Could Deliver 10%+ Upside, AI Analyst Says

According to a report in the Wall Street Journal, Costco ($COST) is about to launch its own Medicare Advantage plan in two states as part of a limi...

Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.

Insiders have been trading these 5 stocks: (($INTC)), (($NFLX)), (($PFE)), (($KO)) and (($JNJ)). Here is a breakdown of their recent trades and the...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	JNJ	$269.73	-2.00%	1.48M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	JNJ	$269.73	-2.0%	1.48M
3
4
5
6

JNJ

Get Johnson & Johnson Data in Excel

Get Johnson & Johnson Data in Excel